Status:
COMPLETED
Safety and Efficacy of Punctum Plug Delivery System in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Lead Sponsor:
Mati Therapeutics Inc.
Conditions:
Glaucoma
Ocular Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine if the Punctum Plug Delivery System (PPDS) is safe and effective in controlling intraocular pressure in patients with open-angle glaucoma or ocular hypertensi...
Eligibility Criteria
Inclusion
- Over 18 yrs with open-angle glaucoma or ocular hypertension
- Subjects who have a best-corrected visual acuity of 20/100 or better.
Exclusion
- Uncontrolled medical conditions.
- Subjects who wear contact lenses.
- Subjects requiring chronic topical artificial tears, lubricants, and/or requiring any other chronic topical medications.
- Subjects who have a history of chronic or recurrent inflammatory eye disease.
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2009
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT00650702
Start Date
March 1 2008
End Date
February 1 2009
Last Update
September 19 2013
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Artesia, California, United States, 90701
2
Sacramento, California, United States, 95815
3
Bel Air, Maryland, United States, 21014
4
Minneapolis, Minnesota, United States, 55404